From: N-terminally truncated Aβ4-x proteoforms and their relevance for Alzheimer’s pathophysiology
Case | PMI (h) | AAO (years) | AAD (years) | Duration (years) | Gender | Diagnosis | Brain weight (g) | APOE | Braak Tau | Thal phase | CERAD | ABC | CAA |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1 | 115:35 | 49 | 54 | 5 | M | AD | 910 | 2/3 | 6 | 5 | 3 | A3B3C3 | 3 |
2 | 33:26 | 63 | 74 | 11 | M | AD | 1022 | 4/4 | 6 | 5 | 3 | A3B3C3 | 3 |
3 | 75:20 | 59 | 75 | 16 | F | AD | 1057 | 3/4 | 6 | 5 | 3 | A3B3C3 | 3 |
4 | 58:50 | 43 | 58 | 15 | F | AD | 1075 | 3/3 | 6 | 5 | 2 | A3B3C2 | 3 |
5 | 85:35 | 72 | 88 | 16 | M | AD | 1120 | 3/4 | 6 | 5 | 3 | A3B3C3 | 1 |
6 | 58:10 | 72 | 88 | 16 | M | AD | 1084 | 2/3 | 6 | 5 | 2 | A3B3C2 | 3 |
7 | 134:20 | 70 | 79 | 9 | M | AD | 1425 | 3/4 | 6 | 5 | 3 | A3B3C3 | 3 |
8 | 60:00 | 62 | 76 | 14 | F | AD | 1020 | 3/4 | 6 | 5 | 3 | A3B3C3 | 3 |
9 | 50:35 | 79 | 88 | 9 | F | AD | 944 | 3/4 | 6 | 5 | 3 | A3B3C3 | 3 |
10 | 90:20 | 70 | 86 | 16 | F | AD | 1065 | 3/4 | 6 | 5 | 3 | A3B3C3 | 3 |
11 | 40:10 | na | 77 | na | M | Control | 1327 | 2/2 | 0 | 0 | 0 | A0B0C0 | 2 |
12 | 29:30 | na | 78 | na | F | Control | 1225 | 2/2 | 2 | 0 | 0 | A0B2C0 | 0 |
13 | 38:50 | na | 71 | na | M | Control | 1480 | 3/3 | 1 | 0 | 0 | A0B1C0 | 0 |